SG/CALL/MODERNA/140/0.1/21.06.24 Stock

Warrant

DE000SQ80AS7

Market Closed - Deutsche Boerse AG 15:38:11 2024-05-10 EDT
0.17 EUR -37.04% Intraday chart for SG/CALL/MODERNA/140/0.1/21.06.24
Current month-22.73%
1 month-26.09%
Date Price Change Volume
24-05-10 0.17 -37.04% 0
24-05-09 0.27 +12.50% 0
24-05-08 0.24 0.00% 0
24-05-07 0.24 -4.00% 0
24-05-06 0.25 -32.43% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 03:38 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MODERNA, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ80AS
ISINDE000SQ80AS7
Date issued 2023-02-13
Strike 140 $
Maturity 2024-06-21 (40 Days)
Parity 10 : 1
Emission price 5.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.29
Lowest since issue 0.12
Spread 0.01
Spread %5.88%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
117.3 USD
Average target price
139.4 USD
Spread / Average Target
+18.79%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW